Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRVL | Common Stock | Options Exercise | $0 | +2.19K | +2.67% | $0.00 | 84.1K | Apr 15, 2025 | By Trust | F1 |
transaction | MRVL | Common Stock | Tax liability | -$57.9K | -1.09K | -1.29% | $53.32 | 83K | Apr 15, 2025 | By Trust | F1, F2 |
transaction | MRVL | Common Stock | Options Exercise | $0 | +1.37K | +1.65% | $0.00 | 84.4K | Apr 15, 2025 | By Trust | F1 |
transaction | MRVL | Common Stock | Tax liability | -$36.2K | -678 | -0.8% | $53.32 | 83.7K | Apr 15, 2025 | By Trust | F1, F2 |
transaction | MRVL | Common Stock | Options Exercise | $0 | +4.5K | +5.37% | $0.00 | 88.2K | Apr 15, 2025 | By Trust | F1 |
transaction | MRVL | Common Stock | Tax liability | -$119K | -2.23K | -2.53% | $53.32 | 86K | Apr 15, 2025 | By Trust | F1, F2 |
transaction | MRVL | Common Stock | Options Exercise | $0 | +2.79K | +3.24% | $0.00 | 88.8K | Apr 15, 2025 | By Trust | F1 |
transaction | MRVL | Common Stock | Tax liability | -$73.7K | -1.38K | -1.56% | $53.32 | 87.4K | Apr 15, 2025 | By Trust | F1, F2 |
transaction | MRVL | Common Stock | Options Exercise | $0 | +33.1K | +37.84% | $0.00 | 120K | Apr 15, 2025 | By Trust | F1 |
transaction | MRVL | Common Stock | Tax liability | -$874K | -16.4K | -13.61% | $53.32 | 104K | Apr 15, 2025 | By Trust | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2.19K | -100% | $0.00 | 0 | Apr 15, 2025 | Common Stock | 2.19K | Direct | F3, F4 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -1.37K | -100% | $0.00 | 0 | Apr 15, 2025 | Common Stock | 1.37K | Direct | F3, F4 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -4.5K | -20% | $0.00 | 18K | Apr 15, 2025 | Common Stock | 4.5K | Direct | F3, F5 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -2.79K | -11.11% | $0.00 | 22.3K | Apr 15, 2025 | Common Stock | 2.79K | Direct | F3, F6 | |
transaction | MRVL | Restricted Stock Units | Options Exercise | $0 | -33.1K | -100% | $0.00 | 0 | Apr 15, 2025 | Common Stock | 33.1K | Direct | F3, F7 | |
transaction | MRVL | Restricted Stock Units | Award | $0 | +48.9K | $0.00 | 48.9K | Apr 15, 2025 | Common Stock | 48.9K | Direct | F3, F8 |
Id | Content |
---|---|
F1 | Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. |
F2 | Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs"). |
F3 | Each RSU represents a contingent right to receive one Marvell common share upon vesting. |
F4 | This grant fully vested on 04/15/2025. |
F5 | The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. |
F6 | The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. |
F7 | The grant is fully vested. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. |
F8 | The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |